The news is that effective from May 20th, 2009, the ODBF Limited Use codes for PLAVIX® have been revised. Please note the revisions to the criteria for the existing codes (i.e. 375 and 376) as well as the addition of a new code (i.e. 411). For access to the criteria, please consult the ODBF website. MI and Stroke and also factor Established Peripheral Arterial Disease PLAVIX® is indicated for the secondary prevention of atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with atherosclerosis documented by stroke, MI, or established peripheral arterial disease. Acute Coronary Syndrome PLAVIX®, in combination with acetylsalicylic acid (ASA), is indicated for the early and long-term secondary prevention of atherothrombotic events (myocardial infarction, ischemic stroke, cardiovascular death and/or refractory ischemia) in patients with acute coronary syndromes – without ST-segment elevation (i.e. unstable angina or non-Q-wave myocardial infarction).
These are the benefits of PLAVIX® which have been shown only when these patients were concomitantly treated with ASA in addition to other standard therapies. These are the benefits were also seen in patients who were managed well medically and those who were also managed with percutaneous coronary intervention (with or without stent) or CABG (coronary artery bypass graft). The patients who have ST-segment elevation acute myocardial infarction, PLAVIX® has been shown to reduce the rate of an endpoint of all-cause mortality and the rate of a combined endpoint of death, reinfarction, or stroke. Plavix is a costly medicine in USA and the generic Plavix is not available in USA. Generic Plavix can be bought from a reputed online pharmacy such as www.genericmedicine.com for much cheaper price and from the online pharmacy you can save more than 70% for what you are currently paying to your regular pharmacy. So do not wait and buy today your generic plavix from our online pharmacy www.genericmedicine.com
|
0 Comments until now
Be heard... Be the first commenter!
Be Heard... Add your Comment!